2005
DOI: 10.1089/aid.2005.21.654
|View full text |Cite
|
Sign up to set email alerts
|

Genomic Characterization of a Novel HIV Type 1 B/G Intersubtype Recombinant Strain from an Injecting Drug User in Germany

Abstract: Recombinant forms of HIV-1 contribute significantly to the ongoing epidemic. In the present study we characterize the full-length genome of a novel B/G intersubtype recombinant strain from a patient with a history of injection drug use. This is the first evidence of a B/G recombinant among injecting drug users in Germany. Moreover, this genetically divergent strain has important clinical implications since it was undetectable in the NucliSens HIV-1 QT assay and significantly underquantified by the COBAS MONITO… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
12
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 16 publications
1
12
0
Order By: Relevance
“…Although 9196/01 has a B/G recombinant composition and contains some regions closely related to CRF14_BG, it is clearly distinguishable from this CRF due to the subtype B-derived region within pol IN [Delgado et al, 2002]. This has since been confirmed based on full length genome analysis [Harris et al, 2005]. The phylogenetic relatedness between 9196/01 and CRF14_BG reference strains supports the contention that this patient was infected in Portugal.…”
Section: Discussionsupporting
confidence: 60%
“…Although 9196/01 has a B/G recombinant composition and contains some regions closely related to CRF14_BG, it is clearly distinguishable from this CRF due to the subtype B-derived region within pol IN [Delgado et al, 2002]. This has since been confirmed based on full length genome analysis [Harris et al, 2005]. The phylogenetic relatedness between 9196/01 and CRF14_BG reference strains supports the contention that this patient was infected in Portugal.…”
Section: Discussionsupporting
confidence: 60%
“…Product 1 of 1.2 kb spanning the 5Ј long terminal repeat (LTR) through gag was generated using RE9737F-2 with M/Op24-7 and RE9745F-2 with M/Op24-6. 7 AATTGGCTCAAAGGTTAC; nt 6846-6871) and 13pef226 (5Ј GGGTTTATTACAGGGACAGCAGAGAC; nt 4900-4925)/ ear26. Product 6 of 1.5 kb env gp120 through env gp41 was amplified with primers ebf27 (5Ј CTATTTTGTGCATCT-GATGCTAAAGCA; nt 6378-6404)/13per27 (5Ј TTAATGC-CCCAGACCGTGAGTTTCAAC; nt 7919-7945) and ebf27/ ebr219 (5Ј TTGTCTGGCCTGTACCGTC; nt 7835-7853).…”
mentioning
confidence: 99%
“…The early nucleic acid-based assays (NAT) used to monitor viral loads in HIV-1 infected patients were impacted by the genetic variability between HIV-1 subtypes resulting in under quantification of or failure to detect some non-B viruses [Swanson et al, 2000[Swanson et al, , 2005Geelan et al, 2003;Harris et al, 2005;Lee et al, 2006]. While the high genetic diversity in HIV-1 continues to pose a challenge for NAT, at least one real-time HIV-1 viral load assay has been designed to address this issue [Swanson et al, 2006a[Swanson et al, ,b, 2007.…”
Section: Hiv-1 Non-b Strains In Usmentioning
confidence: 99%